Paper · 41869723
DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation.
Bruge C and 16 others. JCI Insight, 2026. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation. Papers, record 41869723. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41869723
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipid Metabolism | Major topic |
| Muscular Dystrophies, Limb-Girdle | Major topic |
| Adaptor Proteins, Vesicular Transport | Major topic |
| Adaptor Proteins, Signal Transducing | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Disease Progression | |
| Dysferlin | |
| Muscle Fibers, Skeletal | |
| Induced Pluripotent Stem Cells | |
| Male | |
| Muscle, Skeletal | |
| Female | |
| Disease Models, Animal | |
| Apoptosis Regulatory Proteins |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25,313,409 | Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy. | J Cell Biol | 2014 | https://conductscience.org/library/papers/25313409 | PubMed |
| 2 | 26,290,039 | Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells. | Sci Rep | 2015 | https://conductscience.org/library/papers/26290039 | PubMed |
| 3 | 28,707,952 | Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy. | Hum Gene Ther | 2018 | https://conductscience.org/library/papers/28707952 | PubMed |
| 4 | 31,105,274 | Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases. | Genet Med | 2019 | https://conductscience.org/library/papers/31105274 | PubMed |
| 5 | 29,034,878 | Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 (Rumi). | Stem Cell Res | 2017 | https://conductscience.org/library/papers/29034878 | PubMed |
| 6 | 20,082,313 | Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle. | Muscle Nerve | 2010 | https://conductscience.org/library/papers/20082313 | PubMed |
| 7 | 27,333,044 | Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome. | EBioMedicine | 2016 | https://conductscience.org/library/papers/27333044 | PubMed |
| 8 | 34,831,431 | Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B. | Cells | 2021 | https://conductscience.org/library/papers/34831431 | PubMed |
| 9 | 25,260,700 | HTSeq--a Python framework to work with high-throughput sequencing data. | Bioinformatics | 2015 | https://conductscience.org/library/papers/25260700 | PubMed |
| 10 | 30,439,648 | Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy. | Mol Ther Nucleic Acids | 2018 | https://conductscience.org/library/papers/30439648 | PubMed |
1 to 10 of 80
See all 80 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,406,575 | Excess muscle plasma membrane leak disrupts ECM content and shifts macrophage-mediated muscle repair. | JCI Insight | 2026 | https://conductscience.org/library/papers/42406575 |
Source PubMed
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACTN1 | 87 | PubTator's text mining | https://conductscience.org/library/genes/87 | NCBI Gene |
| AP3B1 | 8,546 | PubTator's text mining | https://conductscience.org/library/genes/8546 | NCBI Gene |
| CMPK1 | 51,727 | PubTator's text mining | https://conductscience.org/library/genes/51727 | NCBI Gene |
| DAB2 | 1,601 | PubTator's text mining | https://conductscience.org/library/genes/1601 | NCBI Gene |
| DES | 1,674 | PubTator's text mining | https://conductscience.org/library/genes/1674 | NCBI Gene |
| DYSF | 8,291 | PubTator's text mining | https://conductscience.org/library/genes/8291 | NCBI Gene |
| EGF | 1,950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| FABP3 | 2,170 | PubTator's text mining | https://conductscience.org/library/genes/2170 | NCBI Gene |
| FER | 2,241 | PubTator's text mining | https://conductscience.org/library/genes/2241 | NCBI Gene |
| FST | 10,468 | PubTator's text mining | https://conductscience.org/library/genes/10468 | NCBI Gene |
1 to 10 of 24
See all 24 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41869723
GET https://conductscience.org/api/papers/v1/41869723/references?page=2